Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
130.2 USD | -0.39% | +2.19% | +13.63% |
Apr. 22 | RBC Capital Adjusts Xylem Price Target to $157 From $153 | MT |
Apr. 18 | Oppenheimer Adjusts Price Target on Xylem to $142 From $133, Outperform Rating Kept | MT |
Evolution of the average Target Price on Xylem Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Xylem Inc.
RBC Capital Markets | |
Oppenheimer | |
BNP Paribas Exane | |
Citigroup | |
Baird | |
Stifel Nicolaus | |
Deutsche Bank Securities | |
Melius Research | |
Seaport Global Securities | |
Goldman Sachs | |
Cowen | |
Morgan Stanley | |
Mizuho Securities | |
Raymond James | |
Atlantic Equities | |
Credit Suisse | |
Argus | |
Berenberg Bank | |
Loop Capital | |
Rosenblatt Securities |
EPS Revisions
- Stock Market
- Equities
- XYL Stock
- Consensus Xylem Inc.